The HHMI Bump

A new study shows a slight citation benefit to authors recently awarded investigator status from the Howard Hughes Medical Institute.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, DVORTYGIRLScientific papers published just prior to their authors being awarded a coveted investigator position at the Howard Hughes Medical Institute (HHMI) are cited 12 percent more than expected, according to new research. The citation bump was more pronounced for papers published in new areas of research or in lower-profile journals. The study, published in this month’s issue of Management Science, compared more than 3,600 life science papers written by 424 HHMI investigators to an equal number of papers written by researchers who had not received the honor. “We found that there was an effect of status,” MIT economist Pierre Azoulay, study coauthor, said in a statement.

Azoulay and his collaborators tracked changes in the citation rates of papers before and after one or more of their authors were named HHMI investigators. They found that citations jumped for some of the papers just after their authors joined the HHMI fold.

“You couldn’t tell them [the pairs of papers] apart in terms of citation trajectories, up until the time of the prize,” Azoulay said.

But the effect was more pronounced in some instances. The citation bump was nearly twice as great for papers published in lower-profile journals, and younger researcher/authors, with less robust reputations prior to their HHMI appointments were more likely to experience the benefits of the award. “The effect was much more pronounced when there was more reason to be uncertain ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies